LUNA Price Unchanged Amid Expanded Wearable Health Integrations

On November 18, 2025, LUNA maintained a stable price of $0.0774 within 24 hours, though it has experienced a decline of 5.77% over the past week, 17.88% over the last month, and a steep drop of 81.5% over the past year. These figures underscore a broader trend of long-term downward movement despite short-term stability. The lack of immediate price movement is attributed to recent developments unrelated to cryptocurrency but rather in the health-tech sector, where LUNA has become a key partner in women’s health tracking.

LUNA, a wearable health device manufacturer, has announced expanded integrations with Clue, a leading period and cycle tracking app used by over 100 million individuals globally. This partnership adds LUNA to a growing list of wearable device companies working with Clue to enhance women’s health insights. The new integration enables users to sync sleep duration and skin temperature data from the LUNA wearable into the Clue app, offering users a more comprehensive view of their health in relation to their menstrual cycles, ovulation, and other life stages.

The partnership is part of Clue’s broader strategy to expand its ecosystem of wearable technology partners, which now includes Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, and Noise. These integrations allow for continuous passive tracking of key biometric data, followed by secure data synchronization and contextual analysis within Clue’s platform. Users can now observe correlations between their sleep patterns, body temperature, and hormonal changes, providing greater visibility into their overall well-being.

For Clue Plus subscribers, the integration includes exclusive offers such as a 15% discount on all LUNA devices and three months of free Clue Plus membership for all LUNA users. These incentives are part of a broader strategy by Clue and its partners to promote the adoption of cycle-aware wearables, which have growing demand among users seeking to better understand their health.

The partnership reflects a strategic move by both Clue and LUNA to meet the increasing consumer interest in wearable technology for health tracking. According to Clue’s internal survey of 1,382 users, more than 60% of respondents expressed a desire to use wearables for health and fitness monitoring, with nearly 40% specifically interested in using such devices for menstrual cycle tracking. This data highlights a strong market opportunity for companies like LUNA to integrate their health data into broader platforms like Clue.

Clue CEO Rhiannon White emphasized the company’s mission to empower users with actionable health insights, stating that the expansion of wearable partnerships is a critical step in achieving this goal. By connecting wearable data with self-tracked symptoms and cycle information, users are better equipped to understand and manage their health in alignment with their bodies’ natural rhythms.

While the news does not directly influence LUNA’s market price, it reinforces the company’s role as a key player in the wearable health technology space. The integration with Clue also highlights a growing trend of cross-platform health data sharing, which may contribute to long-term brand loyalty and user engagement—factors that could indirectly influence investor sentiment in the future.